Malignant melanoma in Europe: changes in mortality rates (1970-90) in European Community countries
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Reducing mortality, especially premature death, is a major goal of the fight against cancer. In this study, we have analyzed trends in malignant melanoma (MM) mortality in the European Community (EC) as a whole and for each country. The data (obtained from the World Health Organization data bank) have been analyzed for the period 1970-90, by age groups (20-44, 45-64, 65-74, 75+ years). Trends are presented as percentage change of mortality rate for each three-year period in comparison with the rate in the first one (1970-72). The mortality from MM in the EC as a whole increased for both genders (men, +89.2 percent; women, +72.6 percent), with statistically significant trends in all age classes. Northern countries experienced mortality changes about 30 to 50 percent less than the EC average increase. Greater changes were seen in southern European countries, in which recent standardized rates are near to those observed in northern European populations. Among Mediterranean people, the highest increase (more than fourfold) was observed in Spain. The significant increase found for the younger age class makes unlikely the risk of misclassification with other skin cancers. No future decrease in MM mortality in the EC is indicated from these data.
- Muir CS, Nectoux J. Time trends: Malignant melanoma of skin. In: Magnus K, ed. Trend in Cancer Incidence. Causes and Practical Implications. Washington DC: Hemisphere Publishing, 1982: 365–85.
- Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol VI. Lyon, France: International Agency for Research on Cancer, 1992; IARC Sci. Pub. No. 120: 952–3.
- Lee JAH. Melanoma. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. Philadelphia, PA (USA): Saunders. 1982: 984–5.
- Armstrong BK, Kricker A. Cutaneous melanoma. Trends in cancer incidence and mortality. Cancer Surveys 1994; 19: 219–40.
- Thorn M, Sparen P, Bergstrom R, Adami HO. Trends in mortality rates from malignant melanoma in Sweden 1953–1987 and forecasts up to 2007. Br J Cancer 1992; 66: 563–7.
- Cristofolini M, Piscioli F, Zumiani G. A program for de-tection of early cutaneous malignant melanoma in the province of Trento (Italy). Am J Dermatopathol 1984; 6(Suppl 1): 283–8.
- Williams HC, Smith S, Du Vivier AWP. Evaluation of public education campaigns in cutaneous melanoma: The King's College Hospital experience. Br J Dermatol 1990; 123: 85–92.
- Pehamberger H, Binder M, Knollamyer, Wolff K. Imme-diate effects of a public education campaign on prognostic features of melanoma. J Am Acad Dermatol 1993; 29: 106–8.
- Rampen FHJ, Van Huystee BEWL, Kiemeney LALM. Practical considerations of melanoma/skin cancer screening clinics. Dermatology 1992; 184: 90–3.
- MacKie RM, Osterlind A, Ruiter D, et al. Report on con-sensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Eur J Cancer 1991; 27: 317–23.
- MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 1992; 304: 1012–5.
- World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1997.
- Doll R. Progress against cancer: an epidemiological assessment. Am J Epidemiol 1991; 134: 675–88.
- Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, eds. Cancer Registration Principles and Methods. Lyon, France: International Agency for Research on Cancer, 1991; IARC Sci. Pub. No. 95: 126–58.
- Franceschi S, Bidoli E, Prati S, Fascioli S, La Vecchia C. Mortality from skin melanoma in Italy and Friuli-Venezia Giulia Region, 1970–89. Tumor i 1994; 80: 251–6.
- Van Der Esch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47: 483–90.
- Scotto J, Pitcher H, Lee JAH. Indications of future decreasing trends in skin-melanoma among whites in the United States. Int J Cancer 1991; 49: 490–7.
- Thorn M, Adami HO, Bergstrom R, et al. Trends in survival from malignant melanoma: remarkable improvement in 23 years. JNCI 1989; 81: 611–7.
- MacKie RM, Hunter JAA, Aitchinson TC, et al. Malignant melanoma in Scotland 1979–89. Lancet 1992; 339: 971–5. D. Balzi et al 92 Cancer Causes and Control. Vol 8. 1997
- Malignant melanoma in Europe: changes in mortality rates (1970-90) in European Community countries
Cancer Causes & Control
Volume 8, Issue 1 , pp 85-92
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Cancer prevention
- Industry Sectors